A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 113.95
GOOG 781.56
MSFT 58.03
FB 129.23
BAC 15.38

Recently Added

EAT 51.00
MDM 5.25
ACBI 14.80
QHC 6.04
LOAN 7.15

Gaining Speed

MDM 5.25
EAT 51.00
MDRX 13.17
VPIG 0.36
KMX 53.12

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More

Get Alerted When News Hits On This Stock - FREE!